Belén Garijo, Merck KGaA CEO (Arne Dedert/picture alliance via Getty Images)
October 16, 2025 11:18 AM EDTUpdated 11:49 AM
Deals
Manufacturing

Mer­ck KGaA is open to more ac­qui­si­tions, but not for its CD­MO unit

Anna Brown

News Reporter

Mer­ck KGaA on Thurs­day said it is look­ing for M&A deals to bol­ster its broad port­fo­lio ex­cept for its CD­MO di­vi­sion, and its out­go­ing CEO …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: No­vo Nordisk’s chair to step down; new board to fo­cus on ‘faster de­ci­sion-mak­ing’

Mark Cuban's on­line phar­ma­cy to part­ner with White House­'s TrumpRx

Af­ter fi­nan­cial trou­bles, Grail rais­es $325M from Hims and oth­ers

CRISPR Ther­a­peu­tics says its new gene edit­ing tool is 'a sig­nif­i­cant ad­vance' over prime edit­ing. Prime Med­i­cine ...

Gala­pa­gos to ex­it cell ther­a­py, with loss of 365 jobs and glob­al sites to shut­ter

sponsored

The ad­vent of dig­i­tal ther­a­peu­tics and what it means for health­care

A service from the Financial Times